← Product Code [DQX](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQX) · K971086 # RADIAL AND FEMORAL ARTERY CATHETER (K971086) _B.Braun Medical, Inc. · DQX · Dec 19, 1997 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQX/K971086 ## Device Facts - **Applicant:** B.Braun Medical, Inc. - **Product Code:** [DQX](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQX.md) - **Decision Date:** Dec 19, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1330 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular ## Indications for Use The Radial and Femoral Artery is a device that is utilized to access an artery for blood sampling and blood pressure monitoring. ## Device Story Radial and Femoral Artery Catheter provides arterial access for blood sampling and blood pressure monitoring. Device is used in clinical settings by healthcare professionals. It functions as a conduit for fluid communication between the artery and external monitoring or sampling equipment. No complex electronics or software involved. ## Clinical Evidence Bench testing only. Finished products undergo physical testing and visual examination per established Quality Control Test Procedures and GMP requirements. ## Technological Characteristics Catheter materials tested per ISO 10993. Mechanical device for arterial access. No energy source, software, or connectivity. ## Regulatory Identification A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel. ## Special Controls *Classification.* Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9. ## Predicate Devices - Arrow Radial Artery Catheter ([K810675](/device/K810675.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} K971086 # II 510(k) Summary of Safety and Effectiveness in Accordance with SMDA'90 B. Braun Medical, Inc 824 Twelfth Avenue Bethlehem, PA 18018 (610)691-5400 March 12, 1997 DEC 19 1997 Contact: Mark S. Alsberge, Regulatory Affairs Manager Product Name: Radial and Femoral Artery Catheter Trade Name: Wire, Guide, Catheter Classification name: Cardiovascular Class II, 80DQX 21 CFR 870.1330 SUBSTANTIAL EQUIVALENCE¹ TO: | Name | 510(k) number | Applicant | | --- | --- | --- | | Arrow Radial Artery Catheter | K810675 | Arrow International Inc, | ## Device Description: In accordance with section 510(k) for the Federal Food, Drug, and Cosmetic Act, B. Braun Medical, Inc. intends to introduce into interstate commerce a Radial and Femoral Artery Catheter. The Radial and Femoral Artery is a device that is utilized to access an artery for blood sampling and blood pressure monitoring. ¹ The term "substantially equivalent" as use herein is intended to be a determination of substantial equivalence from an FDA -regulatory point of view under the Federal Food, Drug, and Cosmetic Act and relates to the fact that the product can be marketed without premarket approval or reclassification. These products may be considered distinct from a patent point of view. The term "substantially equivalent" is not applicable to and does not diminish any patent claims related to this product or the technology used to manufacture the product. {1} 6 ## Material: The Radial and Femoral Artery Catheter composed of materials that have been tested in accordance with the ISO Standard 10993 and have been determined to be suitable for the intended use of this product. ## Substantial equivalence: The Radial and Femoral Artery Catheter is similar in materials, form, and intended use to the Arrow Radial Artery Catheterization Kit cleared by Arrow International Inc. There are no new issues of safety or effectiveness raised by The Radial and Femoral Artery Catheter. ## Safety And Effectiveness: All finished products are tested and must meet all required release specifications before distribution. The array of testing required for release include, but are not limited to; physical testing, visual examination (in process and finished product). The physical testing is defined by Quality Control Test Procedure documents. These tests are established testing procedures and parameters which conform to the product design specifications. The testing instruction records for each of the individually required procedures are approved, released, distributed and revised in accordance with document control GMP’s. {2} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Ms. Kerry S. Hanright Regulatory Affairs Assistant B. Braun Medical Inc. 824 12th Avenue Bethlehem, Pennsylvania 18018-0027 DEC 19 1997 Re: K971086 Radial and Femoral Artery Catheter Regulatory Class: II (two) Product Code: DQX Dated: September 20, 1997 Received: September 24, 1997 Dear Ms. Hanright: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3} This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for *in vitro* diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, ![img-0.jpeg](img-0.jpeg) Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4} 510(k) Number (if known): Device Name: *Radial and Femoral Artery Catheter* Indications For Use: *The Radial and Femoral Artery is a device that is utilized to access an artery for blood sampling and blood pressure monitoring.* *(Division Signature and Neurologist, 510(k) Number)* *Pat R* *(K971086)* (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use ☑ (Per 21 CFR 801.109) OR Over-The-Counter Use ☐ (Optional Format 1-2-96) --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQX/K971086](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQX/K971086) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com